Peter Shields

This study looks at how canakinumab, a drug that reduces inflammation, affects cells in the mouth, nose, and blood of former smokers who are at high risk for lung cancer. The goal is to see if blocking a specific inflammatory protein can slow or prevent cancer growth. About 41 pa…